Basic science of cardiac contractility modulation therapy: molecular and electrophysiological mechanisms
D Masarone, MM Kittleson, A D'Onofrio, L Falco… - Heart Rhythm, 2024 - Elsevier
In heart failure with reduced ejection fraction and heart failure with preserved ejection
fraction, profound cellular and molecular changes have recently been documented in the …
fraction, profound cellular and molecular changes have recently been documented in the …
Bridging the gap in the symptomatic heart failure patient journey: insights from the Italian scenario
M Ziacchi, A Spadotto, S Ghio… - Expert Review of …, 2023 - Taylor & Francis
Background The prognosis for heart failure (HF) patients remains poor, with a high mortality
rate, and a marked reduction in quality of life (QOL) and functional status. This study aims to …
rate, and a marked reduction in quality of life (QOL) and functional status. This study aims to …
Exercise training: the holistic approach in cardiovascular prevention
F Giallauria, T Strisciuglio, G Cuomo… - High Blood Pressure & …, 2021 - Springer
Nowadays, there are robust clinical and pathophysiological evidence supporting the
beneficial effects of physical activity on cardiovascular (CV) system. Thus, the physical …
beneficial effects of physical activity on cardiovascular (CV) system. Thus, the physical …
Human in vitro neurocardiac coculture (ivNCC) assay development for evaluating cardiac contractility modulation
Two of the most prominent organ systems, the nervous and the cardiovascular systems, are
intricately connected to maintain homeostasis in mammals. Recent years have shown …
intricately connected to maintain homeostasis in mammals. Recent years have shown …
[HTML][HTML] Cardiac contractility modulation in patients with heart failure: The added value of cardiac rehabilitation in identification, management, and follow-up
M Ruzzolini, F Giallauria, F Fattirolli, E Venturini… - International Journal of …, 2024 - Elsevier
Despite the developments of new drugs and devices, heart failure (HF) remains burdened
by high morbidity and mortality, representing 1-2% of all hospital admissions in Europe and …
by high morbidity and mortality, representing 1-2% of all hospital admissions in Europe and …
[HTML][HTML] Опыт ведения пациентов с имплантированными кардиовертерами-дефибрилляторами с функцией ресинхронизации и модуляторов сердечной …
КВ Давтян, НА Миронова, ИА Чугунов… - Вестник …, 2023 - cyberleninka.ru
Цель. Оценить возможность и эффективность применения модуляции сердечной
сократимости (МСС) у пациентов с сердечной недостаточностью с низкой фракцией …
сократимости (МСС) у пациентов с сердечной недостаточностью с низкой фракцией …
[HTML][HTML] ЭФФЕКТИВНОСТЬ ИСПОЛЬЗОВАНИЯ МОДУЛЯТОРА СЕРДЕЧНОЙ СОКРАТИМОСТИ У ПАЦИЕНТА С НИЗКОЙ ФРАКЦИЕЙ ВЫБРОСА И …
НА Жукова, ГВ Жуков - Вестник Смоленской государственной …, 2023 - cyberleninka.ru
Цель. Представить клинический случай диагностики и лечения больного с хронической
сердечной недостаточностью с низкой фракцией выброса, которому был …
сердечной недостаточностью с низкой фракцией выброса, которому был …
[HTML][HTML] Utilizzo della Cardiac Contractility Modulation e della Mitraclip in paziente con scompenso cardiaco a frazione moderatamente ridotta ed insufficienza …
A Bellantoni, A Lucchino, G Scalzi, LR Romano… - italiancot.it
Il seguente caso descrive l'approccio multimodale utilizzato per un paziente con
insufficienza mitralica severa e sintomi da scompenso cardiaco refrattari alla terapia medica …
insufficienza mitralica severa e sintomi da scompenso cardiaco refrattari alla terapia medica …